Loading organizations...
Loading organizations...
Pharmaceuticals company developing drugs for neurodegenerative diseases.
Affectis Pharmaceuticals has raised $4.5M across 1 funding round.
Affectis Pharmaceuticals has raised $4.5M in total across 1 funding round.
Affectis Pharmaceuticals has raised $4.5M in total across 1 funding round.
Affectis Pharmaceuticals's investors include Aescap Venture, Bayernkapital, EMBL Ventures, KfW, LSP.
Affectis Pharmaceuticals has raised $4.5M across 1 funding round. Most recently, it raised $4.5M Series D in March 2010.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 22, 2010 | $4.5M Series D | Aescap Venture, Bayernkapital, EMBL Ventures, KfW, LSP |